Lee, Seok-Yong
- Duke University · Biochemistry (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #10,345
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2011 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Biochemistry
NIH Funding · FY2023
Linked Award Amount
$990.4K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#10,345
By linked amount among FY2023 PIs
Earliest Year Loaded
2011
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Lee, Seok-Yong as a PI. Multi-PI records show the full award amount for context.
- 5R35NS097241-08R35Contact PIStructure, function, and pharmacology of neuronal membrane transport proteinsDuke University · Biochemistry (NIH department code)$790.7Kaward amount
- 5R21AI166134-02R21Contact PIMolecular principles of anti-COVID-19 drug uptake by human nucleoside transportersDuke University · Biochemistry (NIH department code)$199.7Kaward amount
Award organization
Organizations that administered FY2023 awards listing Lee, Seok-Yong as a PI.
FY2023 award administered by Duke University (NC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2011First NIH AwardDuke University
- 2011$500K Cumulative Funding
- 2011$1M Cumulative Funding
- 2011$2M Cumulative Funding
- 2011Entered Top 50% NationallyRanked #2232
- 2011Entered Top 25% NationallyRanked #2232
- 2017$5M Cumulative Funding
- 2023$10M Cumulative Funding